Sorry Half, you are wrong again. RECAF is an immunoassy, not a molecular test.
Per an investment presentation by Abbott, they plan to add 12 molecular tests in the next 2 to 3 years. No new immunoassy tests were even mentioned.
GoldSeeker™
I have never shorted nor intend to have any financial interest in BOCX. I am not connected with anyone who trades, shorts or has financial interests in BOCX. I only post facts and my opinions. I do not post on IHUB with different aliases.